KATHERINE HOFFMAN: Open Payments
NPI 1992372361 · BLUE ASH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,100 in 63 payments from 13 companies in 2025. Trend: 2023 $2,384 · 2024 $1,730 · 2025 $1,100
Food & beverage: $1,100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $239 |
| Janssen Pharmaceuticals, Inc | 9 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $165 |
| Lundbeck LLC | 6 | $135 |
| Alkermes, Inc. | 4 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Neurocrine BioSciences, Inc. | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Noven Therapeutics, LLC | 2 | $35 |
Products named: VRAYLAR, CAPLYTA, ABILIFY MAINTENA, INVEGA SUSTENNA, ARISTADA, INGREZZA, TRINTELLIX, SPRAVATO.
Industry payments across OH — which companies pay providers there.
